CD69 and neoplasm: Interestingly, in tumor samples obtained with the 5‐ALA technique, we observed an enrichment of the frequency of CD4+T cells expressing the Trm markers CD69 in the intermediate, metabolic active, tumor area than in core tissues (Figure 2D), whereas no difference was observed regarding the frequency of CD103 expressing CD4+ T cells (Figure 2D).